China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism
China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism Overlapping efficacy data is not unprecedented in the Covid-19 vaccine race and all the findings are above the threshold of 50% efficacy required by regulators for approval. A Sinovac spokesman declined to comment on the numbers from its trials in Brazil, Turkey and Indonesia Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy o...
Source: ndtv.com